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The impact of influenza virus worldwide drives significant efforts and resources into R&D of vaccine 
manufacturing processes. A major challenge is to improve the flexibility of these processes, without substantially 
compromising productivity. As in other biotechnological processes, implementation of a chromatographic 
capturing step is favored since it removes the majority of the impurities (host cell proteins and DNA) and 
concentrates the product before polishing. Over the last years, significant efforts towards the development of 
sulfated membrane adsorbers were made. An improved membrane structure and the direct sulfation of a 
cellulose matrix resulted in a membrane adsorber (SCMA) with pseudo-affinity characteristics which can be 
used in the main chromatographic separation step for influenza virus. 
 
Pore size and ligand density are structural characteristics critical for the performance of the SCMA. For the best 
combination tested, the dynamic binding capacity (DBC) of the SCMA was shown to be 5.6×106 
HAU/mlmembrane, which corresponds to an approximately 5.5 times higher capacity than bead-based media. 
However, both SCMA and bead-based media show a similar performance in terms of product recovery (86%-
96%) and contaminant removal.  
 
Experimental results revealed the importance of operational parameters like virus concentration, flow rate, 
conductivity and elution salt concentration. Therefore, a DoE was used to determine the optimal process 
conditions in terms of product losses in the flow through as well as overall product yield and purity for an 
optimized SCMA using an influenza H1N1 virus strain. Currently undergoing experiments aim the identification 
of the best operating conditions, reevaluation of the DBC and purification performance of the optimized SCMA 
for the same virus strain. The robustness of the process for other virus (e.g. influenza H3N2 and B) is also being 
considered. 
Combining the advantages of a membrane chromatographic support with a chemical modification that is shown 
to be specific for the purification of influenza virus is a significant technological advance. After optimization of the 
SCMA and the respective operating conditions significant improvements in the influenza vaccine production 
process are to be expected. 
 
